document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
1695
document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
document
May 31, 2012 — 00:00
This article proposes a mathematical modeling of longevity and an analysis of longevity risk in the field of demographics and life insurance.
Press Releases
SCOR announces that it has extended the cover level provided by its existing financial coverage facility taking the form of a Nat Cat event-driven guaranteed equity line by EUR 75 million.
Press Releases
Moody's Investors Service has upgraded the insurance financial strength ratings (IFSR) of SCOR SE (SCOR) and various guaranteed subsidiaries to A1 from A2, and SCOR’s subordinated debt rating to A3 from Baa1.
Press Releases
SCOR's first quarter of 2012 results.
Press Releases
SCOR Global Life's Embedded Value results of 2011.
Press Releases
The Combined General Meeting of SCOR SE was held on 3 May 2012 in Paris and was chaired by Mr. Denis Kessler, Chairman and Chief Executive Officer of SCOR SE.
document
May 3, 2012 — 00:00
SCOR Global Life Embedded Value reaches EUR 3.3 billion in 2011 (EUR 18.0 per share), continuing to provide the SCOR group with significant earnings and strong capital repatriation.
